| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 3e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.009 |